QIAcube Connect

Closed Solicitation Posted

Solicitation number
2022-68634
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Place of performance
Atlanta, Georgia 30341, United States

Notice details come from SAM.gov. Updated .

Notice text

The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD)  intends to award a sole source firm fixed price purchase order to Qiagen LLC, Germantown, MD to procure Qiacube Connect Extractor for an automated nucleic acid instrument that provides the high quality next generation sequencing.   This company is the only vendor that can provide this requirement for CDC.

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-l(b) (SAP) and 10 U.S.C. 2304(c)(l). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. 

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Any quotation/response should be emailed to the Contract Specialist,  Beth West at llw5@cdc.gov by close of business on August 26, 2022  @ 12:30 pm, EST.

Files

File Type Posted
RFQ.doc DOC document

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors